Showing 181 - 200 results of 2,564 for search '(( significant decrease decrease ) OR ( significant ((non decrease) OR (a decrease)) ))~', query time: 0.60s Refine Results
  1. 181

    S1 Data - by Francois Kiemde (5369657)

    Published 2024
    “…<div><p>Background</p><p>The hormonal shift occurring in pregnant women is crucial for the outcome of pregnancy. We conducted a study in pregnant women living in a malaria endemic area to determine the potential effect of gestational age on the modulation of the endocrine system by cortisol and prolactin production during pregnancy.…”
  2. 182

    Characteristic of study population. by Francois Kiemde (5369657)

    Published 2024
    “…<div><p>Background</p><p>The hormonal shift occurring in pregnant women is crucial for the outcome of pregnancy. We conducted a study in pregnant women living in a malaria endemic area to determine the potential effect of gestational age on the modulation of the endocrine system by cortisol and prolactin production during pregnancy.…”
  3. 183
  4. 184
  5. 185
  6. 186

    Establishment of a diabetic rat model. by Lan Zeng (638254)

    Published 2025
    “…In addition, RP11-502I4.3 expression was decreased in the retinas of diabetic rats compared with non-diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3B</a>), and it was predominantly localised in the cytoplasm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3C</a>).…”
  7. 187
  8. 188

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  9. 189

    Study populations of included studies. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  10. 190

    Future research directions. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  11. 191

    PRISMA flow diagram. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  12. 192

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  13. 193

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  14. 194

    Participant characteristics of included studies. by Martha R. Smith (20410184)

    Published 2024
    “…Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. In the nine studies that evaluated liver chemistry, no significant changes were observed.…”
  15. 195

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In contrast, the non-recurrence group demonstrated significant and sustained improvement from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 at corresponding postoperative time points (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g005" target="_blank">Fig 5</a>).…”
  16. 196
  17. 197
  18. 198
  19. 199

    This is the raw data used for this study. by James M. Friedman (22522150)

    Published 2025
    “…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”
  20. 200

    Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

    Published 2025
    “…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”